Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000117

EVP Research and Development gave 500 shares (gift)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

STAHL NEIL · EVP Research and Development

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-13 Gift : show line 1 in the form 10b5-1 −500 49,599 D
Loading xslF345X05/edgardoc.xml…